Mucosal Inflammation and Disease in Helicobacter pylori Infection

References

• Marshall B J, Warren J R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311–3
   Google Scholar
• Rauws E A, Langenberg W, Houthoff H J, Zanen H C, Tytgat G N. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94: 33–40
   Google Scholar
• Axon A T. Duodenal ulcer: the villain unmasked? Eradicating H. pylori will cure most patients. BMJ 1991; 302: 919–21
   PubMed Web of Science ®Google Scholar
• Aad A, Unge P. Antibacterial therapy of Helicobacter pylori-associated peptic ulcer disease: a new strategy [editorial]. J Clin Gastroenterol 1994; 272: 6–10
   Google Scholar
• NIH consensus conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65–9
   PubMed Web of Science ®Google Scholar
• Graham D Y, Lew G M, Klein P D, Evans D G, Evans D J, Jr, Saeed Z A, et al. Effect of Helicobacter pylori infection on the longterm recurrence of gastric and duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992; 116: 705–8
   PubMed Web of Science ®Google Scholar
• Meuwissen S GM, Ridwan B U, Hasper H J, Innemee G. Hypertrophic protein-losing gastropathy. A retrospective analysis of 40 cases in the Netherlands. Scand J Gastroenterol 1992; 27 Suppl 194: 1–7
   Google Scholar
• Møller H, Heseltine E, Vainio H. Working group report on schistosomes, liver flukes and Helicobacter pylori. Int J Cancer 1995; 60: 587–9
   PubMedGoogle Scholar
• Parsonnett J, Hanson S, Rodriguez L, Gelb A B, Warnke E A, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267–71
   PubMedGoogle Scholar
• Dooley C P, Cohen H, Fitzgibbons P L, Bauer M, Appleman M D, Perez-Perez G I, et al. Prevalance of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562–6
   PubMed Web of Science ®Google Scholar
• Eaton K A, Morgan D R, Krakowka S. Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun 1989; 57: 1119–25
   PubMed Web of Science ®Google Scholar
• Geis G, Suerbaum S, Forsthoff B, Leying H, Opferkuch W. Ultrastructure and biochemical studies of the flagellar sheath of Helicobacter pylori. J Med Microbiol 1993; 38: 371–7
   PubMed Web of Science ®Google Scholar
• Eaton K A, Brooks C L, Morgan D R, Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991; 59: 2470–5
   PubMed Web of Science ®Google Scholar
• Bode G, Malfertheiner P, Lehnhardt G, Nilius M, Ditschunheit H. Ultrastructural localization of urease of Helicobacter pylori. Med Microbiol Immunol 1993; 38: 371–7
   Google Scholar
• Newell D G, Stacey A R. The serology of Helicobacter pylori infections. Helicobacter pylori and gastroduodenal disease, B J Rathbone, R V Healthley. Blackwell, Oxford 1992; 64–73
   Google Scholar
• Corthesy-Theulaz I, Vaney A C, Haas R, Saraga E, Kraehenbuhl J P, Blum A L, et al. H. pylori urease B subunit as a therapeutical vaccine against H. felis infection. Gastroenterology 1994; 106: A668
   Google Scholar
• Noach L A, Rolf T M, Tytgat G NJ. Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa. J Clin Pathol 1994; 47: 699–704
   PubMed Web of Science ®Google Scholar
• Sherman P M. Adherence and internalisation of H. pylori by epithelial cells. Helicobacter pylori basic mechanisms to clinical cure, R H Hunt, G NJ Tytgat. Kluwer Academic Publishers, Dordrecht 1994; 148–62
   Google Scholar
• Falk P, Roth K A, Boren T, Westblom T U, Gordon J L, Normark S. An in vitro adherence essay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium. Proc Natl Acad Sci USA 1993; 90: 2035–9
   PubMed Web of Science ®Google Scholar
• Boren T, Falk P, Roth K A, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epthelium mediated by blood group antigens. Science 1993; 262: 1892–5
   PubMed Web of Science ®Google Scholar
• Lee A, Eckstein R P, Fevre D I, Dick E, Kellow J E. Non Campylobacter pylori spiral organisms in the gastric antrum. Aus NZJ Med 1989; 19: 156–8
   PubMedGoogle Scholar
• Rathbone B J, Wyatt J I, Worsley B W, Shires S E, Trejdoscewiz L K, Healthley R V, et al. Systemic and local antibody responses to gastric Campylobacter pylorids in non-ulcer dyspepsia. Gut 1986; 27: 642–7
   PubMed Web of Science ®Google Scholar
• Wyatt J I, Rathbone B J. Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol 1988; 23 Suppl 142: 44–9
   Web of Science ®Google Scholar
• Wyatt J I, Rathbone B J, Dixon M F, Heathley R V. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987; 40: 841–8
   PubMed Web of Science ®Google Scholar
• Veenendaal R A, Schroijen V, Götz J M, Peña A S, Roosendaal R, Veselic M, . Salivary-systemic, gastric juice, and gastric mucosal IgA and IgA Helicobacter pylori antibodies in patients with active chronic Helicobacter pylori associated antral and pangastritis. Immunological and serodiagnostic aspects of Helicobacter pylori infection [dissertion], R A Veenendaal, et al. Leiden University, Leiden 1994
   Google Scholar
• Götz J M, Veenendaal R A, Veselic M, Bernards S, Lamers C BHW. Triple therapy with ranitidine, clarithromycin, and metronidazol in the treatment of Helicobacter pylori. Scand J Gastroenterol 1995; 30 Suppl 212: 34–7
   Google Scholar
• De Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817–20
   PubMed Web of Science ®Google Scholar
• Veenendaal R A, Götz J M, Schrojen V, Kurban F, Bernards A T, Veselic M, et al. Diagnosis of Helicobacter pylori infection by specific gastric mucosal IgA and IgG antibodies. J Clin Pathol 1995; 48: 990–3
   PubMedGoogle Scholar
• Peña A S, Endtz H PH, Offerhaus C JA, Hoogenboom-Verdegaal A, Van Duijn W, De Vargas N, et al. Value of serology (ELISA and Immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion 1989; 44: 131–41
   PubMed Web of Science ®Google Scholar
• Gobert B, Bene M C, De Korwin J D, Faure G. Isotype evolution in the follow-up study of patients with Campylobacter pylori associated gastritis. Gastroenterol Clin biol 1989; 13: 880–3
   PubMedGoogle Scholar
• Vaira D, Holton J, Cairns S R, Falzan M, Polydarou A, Dawsett J F. Antibody titres to Campylobacter pylori after treatment for gastritis. Br Med J 1988; 297: 397
   PubMedGoogle Scholar
• Veenendaal R A, Peña A S, Meijer J L, van der Endtz H PH, Est M MC, Van Duijn W, et al. Longterm serological surveillance after treatment of Helicobacter pylori infection. Gut 1991; 32: 1291–4
   PubMed Web of Science ®Google Scholar
• Kosunen T U, Seppälä K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992; 339: 893–5
   PubMed Web of Science ®Google Scholar
• Newell D G, Stacey A R. B cell responses in H. pylori infection. Helicobacter pylori basic mechanisms to clinical cure, R H Hunt, G NJ Tytgat. Kluwer Academic Publishers, Dordrecht 1994; 309–20
   Google Scholar
• Price A B. The Sydney system: histological division. In the Sydney system: a new classification of gastritis. A working party report of the world congresses of gastroenterology. J Gastroenterol Hepatol 1991; 209–22
   PubMedGoogle Scholar
• Grabtree J E. Immunopathological aspects of Helicobacter pylori associatd injury of the gastric mucosa. Mol Med 1994; 31: 130–8
   Google Scholar
• Ernst P B, Jin Y, Nararro, Reyes V, Crowe S. Overview of the immune response to H. pylori. Helicobacter pylori basic mechanisms to clinical cure, R H Hunt, G NJ Tytgat. Kluwer Academic Publishers, Dordrecht 1994; 295–305
   Google Scholar
• Hatz R A, Brooks W P, Krämling H J, Enders G. Stomach immunology and Helicobacter pylori infection. Curr Opin Gastroenterol 1992; 8: 993–1001
   Google Scholar
• Kozol R, McCurdy B, Czanko R. A neutrophil chemotactic factor present in H. pylori but absent in H. mustelae. Dig Dis Sci 1993; 38: 137–41
   PubMedGoogle Scholar
• Mai K EH, Perez-Perez G I, Wahl L M, Blaser M J, Smith P D. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharid-independent mechanism. J Clin Invest 1991; 87: 894–900
   PubMed Web of Science ®Google Scholar
• Neilsen H, Andersen L P. Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leukocytes and monocytes. Gut 1992; 33: 738–42
   PubMed Web of Science ®Google Scholar
• Craig P M, Territo M C, Karnes W E, Walsh J H. Helicobacter pylori secretes a chemotactic factor from monocytes and neutrophils. Gut 1992; 33: 1020–3
   PubMed Web of Science ®Google Scholar
• Yoshida N, Granger D N, Evans D J, Evans D G, Graham D Y, Anderson D C, et al. Mechanisms involved in Helicobacter pylori induced inflammation. Gastroenterology 1993; 105: 1431–40
   PubMed Web of Science ®Google Scholar
• Suzuki M, Miura S, Suematsu M, Fukumura D, Kurose I, Suzuki H, et al. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury. Am J Physiol 1992; 263: G719–G725
   PubMed Web of Science ®Google Scholar
• Fautelin H, Blomberg B, Fredlund H, Jarnerot G, Danielsson D. Incidence of Helicobacter strains activating neutrophils in patients with peptic ulcer disease. Gut 1993; 34: 599–603
   PubMedGoogle Scholar
• McKinlay A W, Young A, Russel R I, Gemmell C G. Opsonic requirements of Helicobacter pylori. J Med Microbiol 1993; 38: 209–15
   PubMedGoogle Scholar
• Davies G R, Simmonds N J, Stevens T RJ, Sheaff M T, Banatvala N, Laurenson I F. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite productions in vivo. Gut 1994; 35: 179–85
   PubMed Web of Science ®Google Scholar
• Götz J M, Van Kan C, Verspaget H W, Veenendaal R A, Biemond I, Lamers C BHW. Helicobacter pylori infection affects manganese—and copper/zinc—superoxide dismutase levels in the gastric mucosa. Neth J Med 1995; 47: A37
   Google Scholar
• Deusch K, Seifarth C, Reich K, Classen M. T cell subsets in H. pylori-associated gastritis. Helicobacter pylori basic mechanisms to clinical cure, R H Hunt, G NJ Tytgat. Kluwer Academic Publishers, Dordrecht 1994; 148–62
   Google Scholar
• Engstrand L, Scheynius A, Pahlson C. An increased number of Gamma/Delta T-cells and gastric epithelial cell expression of the groEL stress protein homologue in H. pylori associated chronic gastritis of the antrum. Am J Gastroenterol 1991; 86: 976–80
   PubMed Web of Science ®Google Scholar
• Dunn B E, Roop R M, Sung C C, Sharma S A, Perez-Perez G I, Blaser M J. Identification and purification of a cPn60 heat shock protein homolog from H. pylori. Infect Immun 1992; 60: 1946–51
   PubMedGoogle Scholar
• Birkholz S, Knipp U, Opferkuch W. Stimulatory effect of Helicobacter pylori on human periferal blood mononuclear cells of H. pylori infected patients and healthy blood donors. Int J Med Microbiol Virol Parabitol Infect Dis 1993; 280: 166–76
   Google Scholar
• Knipp U, Birkholz S, Kaup W, Opferkuch W. Immunosuppressive effect of Helicobacter pylori on human peripheral blood mononuclear cells. Med Microbiol Immunol (Berl) 1993; 182: 63–76
   PubMedGoogle Scholar
• Hussell T, Isaacson P, Grabtree J E, Spencer J. The response of cells from low grade B cell gastric lymphomas of mucosa associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571–4
   PubMed Web of Science ®Google Scholar
• Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno R A. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989; 27: 225–6
   PubMed Web of Science ®Google Scholar
• Lage A P, Glupczynski Y, Goossen H, Burette A, Butzier J P. Neutrolising antibodies to the vacuolating toxin of H. pylori in gastritis only and peptic ulcer patients. Int J Med Microbiol Virol Parasitol Infect Dis 1993; 280: 197–202
   Google Scholar
• Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujikin N. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric carcinoma patients. Int J Cancer 1994; 56: 56–60
   PubMed Web of Science ®Google Scholar
• Tummuro M KR, Cover T L, Blaser M J. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993; 61: 1799–1809
   PubMedGoogle Scholar
• Covaccio A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Ntl Acad Sci USA. 1993; 90: 5791–5
   PubMedGoogle Scholar
• Leunk R D, Johnson P T, David B C, Kraft W G, Morgan D R. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microiol 1988; 26: 93–9
   PubMed Web of Science ®Google Scholar
• Telford J L, Ghiara P, Dell'orco M, Comanducci M, Burroni D, Bugnoli M, et al. Gene structure of Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179: 1653–8
   PubMed Web of Science ®Google Scholar
• Tummuru M KR, Cover T L, Blaser M J. Mutation of the cytotoxin-associated CagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun 1994; 622: 609–13
   Google Scholar
• Cover T L, Tummuru M KR, Cao P, Thompson S A, Blaser M J. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994; 269: 10566–73
   PubMed Web of Science ®Google Scholar
• Schmitt W, Haas R. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol Microbiol 1994; 12: 307–19
   PubMed Web of Science ®Google Scholar
• Atherton J C, Tham K T, Peek R M, Blaser M J, Cover T L. Specific Helicobacter pylori VacA genotypes are associated with presence of duodenal and gastric ulceration and degree of gastric inflammation. Gut 1995; 37 Suppl 1: A3
   Google Scholar
• Czinn S J, Cai A, Nedrud J G. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993; 11: 637–42
   PubMed Web of Science ®Google Scholar
• Chen M H, Lee A, Hazell S, Hu P J, Li Y Y. Immunization against gastric infection with Helicobacter species—first step in the prophylaxis of gastric cancer?. Int J Microbiol Virol Parasitol Infect Dis 1993; 280: 155–65
   Google Scholar
• Doidge C, Gust I, Lee A, Buck F, Hazell S, Manne U. Therapeutic immunization against Helicobacter infection. Lancet 1994; 343: 914–5
   PubMed Web of Science ®Google Scholar
• Monath T P, Thomas W, Weltzin R A, Soman G, Ackerman S A, Pappo J. Progress towards a vaccine against Helicobacter pylori. Am J Gastroenterol 1994; 89: 1380–3
   Google Scholar